RIGL

Rigel Pharmaceuticals Inc

1 day chart

About RIGL

Rigel Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in discovering, developing and providing therapies that improve the lives of patients with hematologic disorders and cancer. The Company's lead product, TAVALISSE (fostamatinib disodium hexahydrate) tablets, the spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia (ITP). Its product also includes REZLIDHIA (olutasidenib) capsules, which are for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. Its other clinical programs include its interleukin receptor-associated kinase (IRAK) inhibitor program and a receptor-interacting serine/threonine-protein kinase (RIPK1) inhibitor program in clinical development. In addition, it has product candidates in clinical development with partners BerGenBio ASA (BerGenBio) and Daiichi Sankyo (Daiichi).

Buy US stocks in Australia starting with RIGL. Open an account and start investing today!

Market Capitalisation

$179.60M

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$1.02

Low today

$0.91

Open price

$0.00

52-week high

$2.04

52-week low

$0.67

RIGL FAQs

Can I buy RIGL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy RIGL shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Rigel Pharmaceuticals Inc?

One share of Rigel Pharmaceuticals Inc is valued at $1.18.

What is the ticker symbol for Rigel Pharmaceuticals Inc?

The ticker symbol for Rigel Pharmaceuticals Inc is RIGL.

How do I buy RIGL shares in Australia?

To buy RIGL stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in RIGL

What is the 52-week high for Rigel Pharmaceuticals Inc stock?

The Rigel Pharmaceuticals Inc 52-week high stock price is $2.04.

What is the 52-week low for Rigel Pharmaceuticals Inc stock?

The Rigel Pharmaceuticals Inc 52-week low stock price is $0.67.

What is the market capitalisation of Rigel Pharmaceuticals Inc RIGL?

As of 04/10/2023 Rigel Pharmaceuticals Inc has a market cap of $180M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.